相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synaptic actin stabilization protein loss in Down syndrome and Alzheimer disease
Julie C. Lauterborn et al.
BRAIN PATHOLOGY (2020)
In vivo imaging of synaptic loss in Alzheimer's disease with [18F]UCB-H positron emission tomography
Christine Bastin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort
Sandra Weintraub et al.
NEUROLOGY (2020)
Targeting Tau Hyperphosphorylation via Kinase Inhibition: Strategy to Address Alzheimer's Disease
Ahmad Abu Turab Naqvi et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
Ellis Chika Onwordi et al.
NATURE COMMUNICATIONS (2020)
Complex formation of APP with GABAB receptors links axonal trafficking to amyloidogenic processing
Margarita C. Dinamarca et al.
NATURE COMMUNICATIONS (2019)
Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study
Hanna Cho et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
Yu Yamazaki et al.
NATURE REVIEWS NEUROLOGY (2019)
18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET
Julie Ottoy et al.
ALZHEIMERS & DEMENTIA (2019)
Altered Insulin Signaling in Alzheimer's Disease Brain - Special Emphasis on PI3K-Akt Pathway
Sami Gabbouj et al.
FRONTIERS IN NEUROSCIENCE (2019)
Increased Inflammation and Unchanged Density of Synaptic Vesicle Glycoprotein 2A (SV2A) in the Postmortem Frontal Cortex of Alzheimer's Disease Patients
Athanasios Metaxas et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
APOE genetic variants and apoE, miR-107 and miR-650 levels in Alzheimer's disease
Michal Prendecki et al.
FOLIA NEUROPATHOLOGICA (2019)
Improved synthesis of SV2A targeting radiotracer [11C]UCB-J
Johanna Rokka et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2019)
Expression of trans-membrane serine protease 3 (TMPRSS3) in the human organ of Corti
Wei Liu et al.
CELL AND TISSUE RESEARCH (2018)
Alzheimer disease: BACE1 inhibitors block new Aβ plaque formation
Charlotte Ridler
Nature Reviews Neurology (2018)
Synaptogyrin-3 Mediates Presynaptic Dysfunction Induced by Tau
Joseph McInnes et al.
NEURON (2018)
Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging
Ming-Kai Chen et al.
JAMA NEUROLOGY (2018)
Activation of TRPC1 Channel by Metabotropic Glutamate Receptor mGluR5 Modulates Synaptic Plasticity and Spatial Working Memory
Sophie Lepannetier et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Effects of APOE Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's Disease
Jingting Dai et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Alzheimers' disease and caregiving: a meta-analytic review comparing the mental health of primary carers to controls
Mandy Ma et al.
AGING & MENTAL HEALTH (2018)
Towards a Better Understanding of GABAergic Remodeling in Alzheimer's Disease
Karan Govindpani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Not just amyloid: physiological functions of the amyloid precursor protein family
Ulrike C. Mueller et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Tau association with synaptic vesicles causes presynaptic dysfunction
Lujia Zhou et al.
NATURE COMMUNICATIONS (2017)
Neuropathological and transcriptomic characteristics of the aged brain
Jeremy A. Miller et al.
ELIFE (2017)
Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology
Stefanie Schreiber et al.
JAMA NEUROLOGY (2017)
Therapeutic Role of Synaptic Vesicle Glycoprotein 2A (SV2A) in Modulating Epileptogenesis
Yukihiro Ohno et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2017)
Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action
Jean-Marie Nicolas et al.
EPILEPSIA (2016)
Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond
Wolfgang Loescher et al.
CNS DRUGS (2016)
TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Yaming Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease
Riqiang Yan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission
Kentaro Tokudome et al.
SCIENTIFIC REPORTS (2016)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
Connecting the dots between tau dysfunction and neurodegeneration
Bess Frost et al.
TRENDS IN CELL BIOLOGY (2015)
Pan-PPAR Modulation Effectively Protects APP/PS1 Mice from Amyloid Deposition and Cognitive Deficits
Markus P. Kummer et al.
MOLECULAR NEUROBIOLOGY (2015)
Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2
Jason D. Ulrich et al.
MOLECULAR NEURODEGENERATION (2014)
A role for tau at the synapse in Alzheimer's disease pathogenesis
Amy M. Pooler et al.
NEUROPHARMACOLOGY (2014)
BACE1 Levels by APOE Genotype in Non-Demented and Alzheimer's Post-Mortem Brains
Boris Decourt et al.
CURRENT ALZHEIMER RESEARCH (2013)
Synaptic vesicle protein 2A: basic facts and role in synaptic function
Julieta Griselda Mendoza-Torreblanca et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
ALZHEIMER'S DISEASE From big data to mechanism
Vivek Swarup et al.
NATURE (2013)
被撤回的出版物: Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease (Retracted article. See vol. 523, 2015)
Herve Rhinn et al.
NATURE (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Tau phosphorylation affects its axonal transport and degradation
Teresa Rodriguez-Martin et al.
NEUROBIOLOGY OF AGING (2013)
The importance of tau phosphorylation for neurodegenerative diseases
Wendy Noble et al.
FRONTIERS IN NEUROLOGY (2013)
Tau elevations in the brain extracellular space correlate with reduced amyloid-β levels and predict adverse clinical outcomes after severe traumatic brain injury
Sandra Magnoni et al.
BRAIN (2012)
MicroRNA regulation of homeostatic synaptic plasticity
Jonathan E. Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
APP and BACE1 miRNA Genetic Variability Has No Major Role in Risk for Alzheimer Disease
Karolien Bettens et al.
HUMAN MUTATION (2009)
Alzheimer's Disease and mild cognitive impairment
Brendan J. Kelley et al.
NEUROLOGIC CLINICS (2007)
Hippocampal volume and retention in Alzheimer's disease
JH Kramer et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2004)
ApoE ε3-haplotype modulates Alzheimer beta-amyloid deposition in the brain
L Myllykangas et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
分享论文
